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Abstract
Our aim is to develop a machine learning (ML) model that can predict
dementia in a general patient population from multiple health care institu-
tions one year and three years prior to the onset of the disease without any
additional monitoring or screening. The purpose of the model is to automate
the cost-effective, non-invasive, digital pre-screening of patients at risk for
dementia.
Towards this purpose, routine care data, which is widely available through
Electronic Medical Record (EMR) systems is used as a data source. These
data embody a rich knowledge and make related medical applications easy to
deploy at scale in a cost-effective manner. Specifically, the model is trained by
using structured and unstructured data from three EMR data sets: diagnosis,
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prescriptions, and medical notes. Each of these three data sets is used to
construct an individual model along with a combined model which is derived
by using all three data sets. Human-interpretable data processing and ML
techniques are selected in order to facilitate adoption of the proposed model
by health care providers from multiple institutions.
The results show that the combined model is generalizable across multiple
institutions and is able to predict dementia within one year of its onset
with an accuracy of nearly 80% despite the fact that it was trained using
routine care data. Moreover, the analysis of the models identified important
predictors for dementia. Some of these predictors (e.g., age and hypertensive
disorders) are already confirmed by the literature while others, especially the
ones derived from the unstructured medical notes, require further clinical
analysis.
Keywords: Dementia, Prediction, Random Forest, EMR, Machine
Learning.
1. Introduction
The recent increase in life expectancy, although desirable, has also re-
sulted in an increase in the number of persons affected by chronic diseases
[1]. Indeed, according to the CDC, one half of the US adult population has
one or more chronic disease [2]. Moreover, chronic diseases are not only the
leading cause of deaths in the US, but also contribute to lower quality of life
and carry a substantial burden on the family, the patient, and the health
care system [3]. In particular, dementia affects a large number of the adult
population. For instance, it is estimated that 5.7 million Americans are liv-
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ing with Alzeihmer’s dementia [4] and this chronic disease is projected to
cost in excess of 1 trillion US dollars annually by 2050 in the US [3]. Identi-
fying persons likely to develop dementia in the future can help support the
development of preventive interventions.
The proposed predictive model is based on a random forest (RF) classi-
fier which is trained by EMR data of dementia and non-dementia patients
from a large number of health institutions in Indiana. These data are ob-
tained from the Indiana Network for Patient Care and Research through the
Regenstrief Institute. Prescriptions (Rx), diagnosis (Dx) and medical notes
(Nx) are extracted from the records of the patients. The Rx and Dx data are
structured, while the Nx data are unstructured (i.e., free text). These data
sets are augmented with demographic information (i.e., age, gender, race and
institution affiliation). Different dimension reduction techniques are used for
each data set and the resulting data sets are used to derive models with one
and three years prediction horizons prior to the onset of dementia.
This prediction horizon may provide the opportunity for early screening
and for delaying the onset of the disease through adequate health plan-based
interventions. In fact, it was estimated that delaying the onset of the disease
by one year can help reduce cost by as much as 14% [3].
2. Background
Extensive research work has been devoted to developing data-driven ML
models that can automate disease diagnosis and prognosis in recent years
[5, 6]. This section includes a brief review of related ML studies from the
following aspects: 1) data sources, 2) feature engineering, 3) ML techniques,
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and 4) target applications. The review primarily focuses on dementia and
discusses the scalability and interpretability of the sources and techniques as
these represent key requirements for our proposed model. A summary of a
selected set of most relevant previously proposed ML models is included in
Table 1.
2.1. Data Sources
Data sources for ML models fall under two broad categories: struc-
tured (e.g., diagnosis, prescriptions, images, medical tests, etc...) and un-
structured (e.g., medical notes).
Most previous dementia models are derived by using structured data from
targeted medical tests (e.g., MRI [10, 8, 12, 13, 14] and cognitive tests [7, 15,
16, 17]). For instance,
- Cognitive tests for a cohort of 400 patients are used in [7],
- Neuropsychological tests for a cohort of 321 patients are used in [9],
- A combination of MRI images and cognitive tests are used in [10] for
a cohort of 825 MCI patients, and
- MRI images, PET scans and cerebrospinal fluid (CSF) from 186 pa-
tients are used in [8].
The extensive use of structured data is not limited to dimentia studies but
also extends to other healthcare areas with a large portion of structured
data being images [6]. This data category is appealing because it requires
relatively limited pre-processing compared to unstructured data. However,
the underlying tests are expensive to administer which in turn restricts the
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Table 1: Summary of target applications, data sources, machine learning techniques, pre-
diction horizons and accuracies for a selected set of most relevant previous studies. X/Y
is used to denote the classes of the model (e.g., AD/HC denotes AD patients versus HC).
MCI-to-AD is used to denote the conversion from MCI patients to AD patients. When
multiple techniques are used in a study, the technique with the highest performance is
reported. HC = Healthy Controls, MCI = Mild Cognitive Impairment, AD = Alzheimer’s
Disease. (*) Dementia, AD, MCI not included.
Target Data ML Pred. Acc.
Disease Source Technique Horizon
[7] MCI-to-
Dementia
Cognitive tests SVM 0.5-4
yrs
76%
[8]-a MCI/HC,
AD/HC
MRI, PET, CSF SVM 0 83%,
93%
[8]-b MCI-to-AD MRI, PET, CSF SVM 2 yrs 74%
[9] AD/MCI/HC Neurophysilogical
tests
BN 0 83%
[10] MCI-to-AD Cognitive tests,
MRI
RF 0-3yrs 82%
[11] multiple∗ EMR RF 0-1yr > 85%
proposed HC-to-
dementia
EMR RF 1 yr 77%
proposed HC-to-
dementia
EMR RF 3 yrs 74%
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inclusion criteria as exemplified by the above studies. Moreover, this aspect
also limits the scalability of the models derived from these sources to a large
population.
Wearable and home devices, an emerging source of structured data, may
help overcome the above restriction. For example, accelerometor data from
an ankle bracelet was used in [18] to model gait and movement activities
for dementia patients and healthy controls (HC). A multisensor home device
was used to monitor the daily activities of ten dementia patients and HC
in [19]. A comprehensive discussion on the use of these devices and their
potential contribution to dimentia detection and monitoring is provided in
[20]. The authors mention that while these devices can become ubiquitous,
their main disadvantage is privacy infringement. That said, as the sensor
technology continues to mature, it is foreseeable that EMR records will start
incorporating this source of patient-provided data.
Unstructured data in health applications is primarily extracted from med-
ical notes. Using this source of data is a new area of research [5]. It was used
to develop models for different disease conditions (e.g., Type-2 diabetes [21],
heart failure [22], colorectal cancer [23] and early readmission for psychiatric
patients [24]). A large number of patient health records from a single health
care institution consisting of both structured and unstructured data was used
in [11] for the prediction of the onset of multiple disease conditions.
The use of medical notes for the development of dementia models in
the literature is scarce. One example study [25] considers text notes for
visits and medical history from the ADNI data set. The model proposed
in this paper also uses structured and unstructured data and confirms the
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findings of previous studies [11, 25] which concluded that combining these
two data sources yields ML models with better performance than each source
individually.
There are recent sources of unstructured data that are gaining impor-
tance in health care applications and may benefit dementia prediction. For
example, transcripts of daily conversation are used in [26] to identify social
behavior (e.g., giving advice, receiving advice, conversation). Another study
[27] uses speech samples and MRI data from 32 semantic dementia patients
and 10 HC.
2.2. Feature Engineering
Both structured and unstructured data must be transformed into a fea-
ture vector that can be used as an input to the ML model. Feature selection
for structured data is relatively well studied. In the case of numerical data
(e.g., age, blood pressure) and categorical data (e.g., gender, disease condi-
tion), the process is either guided by human experts [17] or relies on a well
established nomenclature (e.g., disease codes or drug groups) [11]. A more
difficult procedure is required to transform free text into structured features
[5].
A preliminary step in processing free text consists of syntactic transfor-
mations such as removing punctuation and stop words [26]. This is followed
by a process which identifies features that are representative of the text.
Techniques for feature extraction from free text range from frequency-based
to more advanced techniques that employ autoencoders and deep neural net-
works. A review of the latter two techniques in health care applications is
provided in [5].
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Selecting features based on the most frequent keywords is referred to as
bag of words and was used in [25]. A mapping technique that can further
reduce the feature space and enhance the entropy of each feature consists of
grouping a set of related keywords under a single concept. For example, using
latent Dirichlet allocation (LDA), keywords are grouped by concept in [11]
and [26]. Word2vec [28] and autoencoders have also been used for keyword-
to-concept mapping in several health care applications [5]. LDA, word2vec
and autoencoders are computationally expensive [29] and may select features
that are not interpretable [30]. For these reasons and because of the size of
the corpus which is derived from a large number of different types of medical
notes in this paper, we designed a variant of the bag of words. This approach
is inspired by [28] and selects features based on the differential frequency of
the keywords in dementia cases and healthy controls rather than an absolute
frequency. The modified bag of words used in this study is scalable and
interpretable.
2.3. ML Techniques
The choice of the ML technique is highly dependent on the application
domain and the source of the data [6]. For instance, support vector machine
(SVM) [31], RF [32] and aritificial neural networks (ANN) [33] are used in [7]
to identify conversion from mild cognitive impairment (MCI) to dementia.
The SVM model had the highest accuracy (76%) and the RF model ranked
second best (73%). However, the SVM model had significantly lower sensi-
tivity. RF is also used in [10] to predict conversion from MCI to Alzheimer’s
Disease (AD) with an accuracy of 82%. In [8], SVM was used to classify MCI
and AD patients versus HC with an accuracy of 83% and 93%, respectively.
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Naive Bayesian network (BN), SVM and ANN are used in [9] to develop a
multi-class classifiers for MCI, AD and HC with accuracies of approximately
83%, 60% and 82%, respectively.
It is hard to adequately compare the performance of different ML tech-
niques across multiple studies because of variances in the sources of data,
features and number of records in the training and validation data sets.
However, one common aspect of all of the above studies is that they use
structured data with relatively small number of features.
Despite feature reduction, when a model uses unstructured data, the
number of features still remains large and thus the feature space is highly
dimensional. RF is often the ML technique of choice in these cases. For
example, in [11] once feature reduction is performed on the medical notes
by using LDA, a multi-class RF classifier is trained to identify future disease
conditions for each patient. SVM and RF are used in [26] to classify fea-
tures extracted from transcription of daily conversations by using LDA into
different social behavior classes. In this case, RF had better accuracy and
precision than SVM.
For the dementia prediction model being proposed in this paper, we opted
to use RF. This choice was motivated by several factors that were derived
from the literature and from our own preliminary investigation. Namely, RF
is interpertable, computationally efficient and can handle a high dimensional
space of noisy, continuous and categorical features [34, 35, 36]. That said,
we also experimented with SVM and ANN. SVM had a comparable accu-
racy but was not as interpretable as RF [35]. ANN had a lower accuracy
compared to both RF and SVM, primarily because the number of available
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patient records is much lower than what would be needed to adequately train
a high dimensional deep neural network. Similar observations are made in
[26]. In addition, ANNs are also not interpretable [5]. BN was not consid-
ered since an efficient BN model requires significant engineering effort and
is computationally demanding especially for a model with a large number of
features [32].
2.4. Applications
The accuracy of predictive ML applications depends on the prediction
horizon and the ability to infer the outcome from the evidence. Applications
with short-term horizons support diagnosis whereas applications with long-
term horizons support prognosis. The latter are for early pre-screening and
therefore are most useful when the horizon is long enough to allow adequate
intervention.
Typically, short term horizon applications are based on evidence available
up to the time of occurance of the target outcome. This temporal proximity
allows the use of evidence with a higher entropy. For example, in [9], the
evidence (e.g., age, gender, education, functional ability and visual memory)
is used to classify patients into three classes: HC, MCI and dementia.
In [8], the authors first create short prediction horizons models that clas-
sifies MCI versus HC and AD versus HC. These models show that discrimi-
nating between AD and HC has a higher accuracy compared to MCI versus
HC. This result is anticipated since AD indicators are typically stronger. The
authors then create a model dedicated to the conversion of MCI to AD with
a prediction horizon of 2 years. This model did not have access to evidence
within the prediction horizon, and therefore had a lower accuracy than both
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short term models (Table 1). Models for HC to AD or HC to MCI conver-
sion with a 2 year horizon were not available for comparison with the models
proposed in this paper.
MCI to dementia and MCI to AD conversion models are introduced in
[7] and [10], respectively. These models did not segregate patients according
to the prediction horizon. Therefore, the outcome and the evidence can be
from 0.4 to 4 years and 0 to 3 years apart, respectively.
A general model for the prediction of the onset of multiple diseases (e.g.,
cancer, diabetes, and schizophrenia) with an accuracy greater than 85% was
introduced in [11]. As mentioned above, this model uses structured and
unstructured EMR data from a single institution. However, dementia is not
included as a target disease. Moreover, the prediction horizon is 0 to 1 year
from the time of evidence and varies across the patients.
In the current study, we removed the records of MCI patients in order
to ensure that they do not bias the proposed model which is intended for
the prediction of dementia in a general patient population. Furthermore, no
evidence is used within the prediction horizon of 1 year or 3 years for all
patients.
3. Methods
In order to train and test the proposed models, a group of dementia
(cases) and non-dementia (controls) patients are identified. The processing
steps used to extract the training and testing data from the EMR database as
well as the methodology used to develop the predictive models are discussed
in the next two subsections.
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3.1. Data Preprocessing
The dementia cases are identified by using their diagnosis code. Only
cases of incident dementia are retained. MCI or prevalent dementia cases
are excluded in order to avoid the bias they may introduce in the model.
The diagnosis date (index date) for each case is then established and 3 to 4
matching controls are identified for each case. The matching criteria between
the cases and controls are based on birth year, gender, race and index date
(within 6 months).
For both cases and controls, a query was developed to retrieve all the
medical records within 10 years prior to the index date. Only patients that
had at least one encounter per year were retained. However, patients may
or may not have complete records that span the entire 10 year period (e.g.,
patients that seek additional treatment outside the network, partially mi-
grated patient records from a legacy EMR system). This query resulted in
2,159 cases and 11,558 controls from 15 and 25 different institutions, respec-
tively. The distribution of both cases and controls across the institutions is
not uniform. Moreover, patients may have records spanning multiple insti-
tutions. With respect to race and gender, the distribution of the cases and
controls (Table 2) is similar, thereby limiting any gender or race bias among
the two classes. However, Table 2 shows that within a class, there are more
females and more patients of race white than the other gender and races.
This reflects the demographic of incident dementia patients in Indiana.
Features are extracted from the prescription (Rx), diagnosis (Dx) and
medical notes (Nx) of the EMR record of each patient. Age, gender, race
and institution are also included as features in all models. In the case of insti-
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Table 2: Demographics of the cases and controls.
African American White Other
Male Female Male Female Male Female
Cases 10% 21% 23% 41% 2% 4%
Controls 11% 19% 24% 42% 1% 3%
tution, if a patient is associated with multiple institutions, for each data set,
the most recent institution on record during the model period was selected.
Feature reduction for each data set is performed by using a different
approach. Each Rx feature corresponds to a drug group according to the
Generic Product Identifier (GPI) classifier [37] for a total of 100 features.
The value of the feature is the number of times a medication from the given
drug group was prescribed for the patient within the model period. Age,
gender, race and institution (InstRx) are added to the drug groups in order
to construct a feature vector with 104 features. A similar approach was used
in [35].
A total of 19 dementia related disorders (Table 3) are identified using
expert opinion. These groups of disease conditions are represented by using
ICD-10 or ICD-9 codes in the EMR database. Codes for the target dis-
ease groups were identified and the relevant records for each patient were
extracted. The value for each feature in the Dx data sets corresponds to the
count of the diseases in the corresponding disease group during the model
period. As in the case of prescriptions, age, gender, race and institution (In-
stDx) are added to these features in order to form a Dx feature vector with
23 features.
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Table 3: List of dementia related disorders or disease groups in Dx.
Angina Chronic Ischemic Heart Disease
Anxiety Transient Ischemic Attack
Abnormal Weight Loss Transient Ischemic Attack Related Syndromes
Bipolar Disorder Other Acute Ischemic Heart Disease
Depression Stroke/Cerebral Infarction
Insomnia Acute/ Subesequent MI
Hypercholesterolemia Hemorrhagic Cerebrovascular accident
Hypertensive Disorders other Cardiovascular diseases
Schizophrenia Claudication/Atherosclerosis
Sleep Apnea
Medical notes are a sequence of records starting with the patient’s unique
ID, the date of the record followed by a list of reports. Each report consists
of a report type and a report content in the form of unstructured free text.
There is a total of 2,146 different report types. This large number of report
types is due, in part, to the fact that each institution may use its own set of
reports. In addition, there is a large number of administrative reports such
as “attending MD”, “encounter ID”, “signature”, “enterer ID”, “verified by”
and “dictated by”. These administrative reports are excluded. A total of
340 different report types out of the original 2,146 report types are retained.
The retained report types consist of notes or findings recorded by the health
care provider such as “radiology impression”, “recommendation”, “history of
present illness”, “md progress note” and “social history”. An example report
is shown below:
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<p>EXAM: KUB SINGLE VIEW</p><p>HISTORY: Recurrent left flank
pain. History of nephrolithiasis.</p><p>FINDINGS:</p><p>The
bowel gas pattern is nonspecific but does not appear grossly
<br/>obstructive.</p><p>The renal shadows are obscured by
stool/bowel gas. No definitive<br/>calculi are appreciated.
</p><p>IMPRESSION: Negative KUB.</p><p>Read By: Malaz Boustani
<br/>Reviewed and Electronically Signed By: Malaz Boustani<br/>
</p></text></text_report>
The processing of free text in the medical notes start with the preliminary
syntactic transformation described in Section 2.2. This is a procedure which
is commonly applied to free text [6]. When using the bag-of-word approach,
the next step consists of selecting the keywords with the highest count as
features [24]. However, some of the frequent keywords may be informative
(e.g., abdomen) while others (e.g., patient, doctor, nurse) may not include
significant information towards the target outcome. In fact, the sub-sampling
of some frequent words should be considered as recommended in [28].
In the traditional bag of word, the keyword count is talied in all notes
irrespective of whether the note is attributed to cases or controls. Inspired
by [28], we calculate the count of each keyword with respect to the class (i.e.,
cases or controls). For example, the keyword abdomen occurs 16,988 times
in cases reports and 65,635 times in controls reports. Based on the number
of cases and controls in the study, the difference in relative count for this
keyword is 16, 988/2, 159 (cases) - 65, 635/11, 558 (controls) = 2.19. This
differential frequency is defined as follows:
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DF (keyword) =
∣∣∣∣count(keyword|cases)number of cases − count(keyword|controls)number of controls
∣∣∣∣ (1)
The value of DF tends to be closer to zero for equally frequent keywords
in cases and controls. However, when the keyword is more prevalent in cases
than controls or vice-a-versa, the value of DF is high.
In this study, a total of 173,972 unique keywords are identified. Clusters
are constructed from these keywords using Algorithm 1. First, each keyword
with DF > 1.0 is selected as a seed of a cluster. Other keywords are assigned
to these clusters if their distance to the keywords in the cluster is less than a
given threshold. This assignment is human-validated at each iteration with
the assistance of an online medical dictionary. Most of the clusters included
a large number of keywords for various reasons. Spelling errors are the most
common reason. For instance, there are 43 different incorrect spelling of the
word abdomen (e.g., abbdomen, abdoomen, obdomin, etc.). Conceivably,
spelling errors can be eliminated with a spell checker. However, this implies
that medical notes from future patients need to also be corrected for spelling.
In order to avoid this processing step, the incorrect spellings of each keyword
were kept in the cluster.
In total, 110 clusters were constructed by using the above procedure. The
resulting Nx feature vector includes these clusters of keywords in addition to
age, gender, race and InstNx for a total of 114 features.
3.2. Model Development
The previous data processing steps are used to construct Rx, Dx, and Nx
training and testing data sets for various dementia prediction models. The
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Data: Keyword list L, number of cases, number of controls
Result: A set of clusters where each cluster is an Nx feature
for ki ∈ L do
if DF (ki) > 1.0 then
assign ki to ci
end
end
C = set of ci
while not done do
foreach kj /∈ C do
foreach ki do
if distance(kj, ki) < threshold then
assign kj to ci
end
end
validate
end
end
Algorithm 1: Clustering algorithm for NX features.
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1Y r model is trained and tested by using the available records during the
period (index date - 10 years) to (index date - 1 year). Similarly, the 3Y r
model is trained and tested by using the available patient records during the
period (index date - 10 years) to (index date - 3 years). The aim of these
models is to predict dementia one year and three years prior to the onset of
the disease.
The number of cases and controls in the training and testing data sets
for each model is shown in Table 4. In order to avoid class imbalance a
50/50 split between cases and controls is maintained in the training data set.
Moreover, for cases an 80/20 split is maintained between the training and
testing data sets.
Table 4: Number of cases and controls in the training and testing data sets for each
dementia model.
Model
Training Testing
Cases Controls Cases Controls
1Y r 1,728 1,728 431 9,830
3Y r 869 869 216 4,817
1Y rs 1,225 1,225 299 2,167
Most of the patients in the data set are affiliated with multiple institu-
tions, in which case the value of InstRx, InstDx, and InstNx represents the
most recent institution on record for the patient during the model period.
The 1Y rs model (Table 4) has the same period as the 1Y r model. However,
it only uses patients that are affiliated with a single institution. Patients that
are affiliated with multiple institutions in a given data set are excluded. This
model was developed in order to better understand the impact of institution
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affiliation.
RF is used to train all the models. The hyperparameter of the RF include
the number of trees and the number of features which are presented to each
node of the tree. In [38], a number of trees in the RF equal to the number of
features in the model is recommended. In [34], it is recommended to increase
the number of trees until the model stabalizes. In this study, we experimented
with 100, 500, and 1000 trees and did not find a significant difference. The
performance metrics reported in the result section are for 500 trees in each
model. The second hyperparameter is the number of features presented to
each node in the tree. In this study, it is set to
√
n, where n is the number of
features in the model as recommended in [32]. Moreover, the best dementia
vs non-dementia classification at each node is measured by using the Gini
Impurity (GI) [39].
When the models are validated using the test data sets, the accuracy,
sensitivity and specificity of the models are computed. In addition, features
that are strong predictors for each model are identified. The approach used
to identify these predictors is based on the selection of each node in the clas-
sification decision of the patient [40]. This approach is used in [40] and [41] to
identify important features for RF models aimed at predicting cardiovascular
risk and cancer mortality, respectively. As each patient in the test data set
is classified, a count is maintained of the number of nodes associated with
each feature that are traversed in the decision tree. This count represents the
number of times each feature (fi) participates in the classification decision.
This metric is labeled CD(fi) in the remainder of the paper. As in [40] and
[41], the features with the highest CD(fi) are reported as strong predictors.
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4. Results
The performance metrics corresponding to the various models are shown
in Table 5. These metrics are the mean and standard deviation across the 5
groups in a 5-fold cross validation. The first three sections of this table are
dedicated to the models developed by using the Rx, Dx and Nx data sets,
respectively. The last two sections report the results associated with models
that are trained by using a data set that combines the Rx, Dx and Nx. This
combined data set (RDNx) consists of all the features from the above three
data sets where the duplicate age, gender and race features are removed for
a total of 235 features. As previously mentioned, each data set includes a
feature that represents the institution of the patient (e.g., InstRx for the Rx
data set). The combined RDNx data set includes the three institutions from
the three underlying data sets, namely, InstRx, InstDx, and InstNx. The
last section of Table 5 reports the results associated with a model developed
using the combined data set without these three institution features (RDNx
w/o Inst).
Table 6 shows the top predictors for cases and controls for the models
developed by using the individual data sets. Similarly, Table 7 shows the top
predictors for the models developed by using the combined data sets. Only
the top five ranked features are reported (i.e., with the highest five CD).
The top predictors can be different for cases and controls as shown in tables
6 and 7.
An effort was made to train the models with the same patients. This was
done in order to avoid variations due to different patients (e.g., complete vs.
incomplete records) and number of patients. In general, the more records
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Table 5: Accuracy, sensitivity and specificity for the 1Yr and 3Yr dementia prediction
models trained by using different data sets. For each metric, the entry in the table cor-
responds to the mean value of all groups in a 5-fold cross validation and the number in
parenthesis is the standard deviation across the groups.
Model Accuracy (%) Sensitivity (%) Specificity (%)
Rx
1Y r 70.39 (0.88) 68.94 (2.35) 70.46 (0.98)
3Y r 65.63 (1.24) 65.00 (3.91) 65.65 (1.43)
1Y rs 67.93 (0.94) 72.24 (3.02) 67.33 (1.47)
Dx
1Y r 65.21 (0.74) 66.06 (2.44) 65.18 (0.80)
3Y r 62.91 (1.71) 63.80 (4.26) 62.87 (1.95)
1Y rs 69.27 (1.69) 65.15 (3.37) 69.84 (2.22)
Nx
1Y r 74.07 (0.98) 72.01 (1.72) 74.16 (1.01)
3Y r 70.13 (2.65) 67.31 (3.28) 70.25 (2.85)
1Y rs 78.47 (1.44) 73.04 (2.98) 79.22 (1.97)
RDNx
1Y r 77.43 (1.89) 76.01 (1.88) 77.49 (2.02)
3Y r 73.50 (2.03) 70.93 (2.18) 73.61 (2.17)
1Y rs 79.68 (1.29) 76.35 (2.10) 80.15 (1.30)
RDNx w/o
Inst
1Y r 72.64 (0.34) 73.97 (3.23) 72.58 (0.41)
3Y r 67.88 (1.82) 68.52 (3.48) 67.85 (1.96)
1Y rs 78.60 (0.32) 75.05 (1.22) 79.09 (0.28)
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Table 6: Strong predictors for models trained by using individual data sets. Features with
the top five CD are reported for each model. When the strong predictors for the two
classes (i.e., cases/controls) differ, they are reported separately.
Rx
1Y r InstRx, Age, Antidepressants, Diuretics, Antihyperlipidemics
3Y r InstRx, Age, Antihyperlipidemics, Antidepressants, Antihy-
pertensives
1Y rs InstRx, Age, Antidepressants, Psychotherapeutic & Neuro-
logical Agents - Misc., Analgesics - Opiod
Dx
1Y r InstDx, Age, Hypertensive Disorders, Hypercholesterolemia,
Chronic Ischemic Heart Disease
3Y r InstDx, Age, Hypertensive Disorders Hypercholesterolemia,
Chronic Ischemic Heart Disease
1Y rs cases : InstDx, Age, Hypertensive Disorders, Depression, Hy-
percholesterolemia
controls : InstDx, Age, Hypertensive Disorders, Hypercholes-
terolemia, Chronic Ischemic Heart Disease
Nx
1Y r cases : InstNx, Age, accurate, independently, oral
controls : InstNx, Age, accurate, independently, oldest
3Y r cases : InstNx, Age, accurate, oral, independently
controls : InstNx, Age, accurate, independently, oral
1Y rs cases : InstNx, accurate, oldest, independently, participate
controls : InstNx, Age, radiology, accurate, independently
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Table 7: Strong predictors for models trained by using the combined data sets. Features
with the top five CD are reported for each model. When the strong predictors for the two
classes (i.e., cases/controls) differ, they are reported separately.
RDNx
1Y r cases : InstNx, InstRx, Age, InstDx, oldest
controls : InstNx, InstDx, InstRx, oldest, Age
3Y r cases : InstNx, InstDx, InstRx, oral, oldest
controls : InstDx, InstRx, oral, oldest, Antihyperlidemics
1Y rs cases : InstNx, oldest, participate, independently, InstRx
controls : InstNx, Age, InstRx, oldest, participate
RDNx w/o Inst
1Y r cases : Age, accurate, oldest, independently, oral
controls : Age, accurate, oldest, independently, participate
3Y r Age, oldest, accurate, participate, oral
1Y rs cases : Age, participate, accurate, oldest, independently
controls : Age, participate, accurate, oldest, oral
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available to train an ML model, the higher the accuracy of the model. The
quality of the data is also important. Missing and incomplete data may lead
to poor predictive performance. In this study, the number of patients was
not only limited by the number of cases but also the number of cases that
had Nx data. Moreover, fewer patients are available for the training of the
3Y r compared to the 1Y r models (Table 4). This indicates that the data set
includes a large number of patients that had less than three years of complete
medical records prior to the index date. Similarly, there are fewer patients
available for the training of the 1Y rs compared to the 1Y r models (Table
4). The difference in this case is due to patients that tend to seek treatment
from one institution versus multiple institutions.
5. Discussion
Several observations can be drawn from the results shown in Table 5.
Some of these observations are expected while others are worth discussing.
The 1Y r models have higher accuracy, sensitivity and specificity than the
3Y r models. This is expected since the former models are trained with more
patients and have access to more recent records of the patients prior to the
onset of the disease. For example, the 1Y r and 3Y r Rx models have an
accuracy of 70.39% and 65.63%, respectively. They were trained with 3,456
and 1,738 patients, respectively.
Among the three data sets (i.e., Rx, Dx and Nx), Nx generated models
with the highest accuracy, sensitivity and specificity. Moreover, the accuracy
of the model derived by using the combined RDNx data set is higher than
the models derived by using the individual data sets. This is an indication
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that, despite the fact that Nx models have a higher prediction accuracy,
some of the Rx and Dx features (e.g., antihyperlidemics) make a significant
contribution to the overall accuracy of the combined model.
The most interesting aspect of the analysis is, undoubtedly, associated
with the features that contribute the most to the predictive models. As shown
in tables 6 and 7, cases and controls nearly have the same top predictive
features across all models. Moreover, with respect to patient’s demographics,
age is consistently among the top features of all the models for both cases and
controls. This is particularly interesting since the match between cases and
controls was based on age, gender and race. Gender and race do not, however,
appear as top features in any of the models and are unlikely, according to
these models, to be significant predictors of dementia.
The institution feature is also present in most models as a top feature.
In most cases, the 1Y rs models have higher accuracy than the 1Y r models
despite the fact that they were trained using fewer patients. Moreover, the
combined model based on the RDNx data set includes all three institutions
from the Rx, Dx, and Nx data sets as top features. The importance of
the institution as a feature in the predictive models is intriguing and we
hypothesize that it may due to various reasons including the following:
- An artifact of the way the medical records of the patients are stored or
extracted from the information systems of the various institutions.
- An indication of the completeness of the health record of the patients.
- An indication of the socio-economic demographics of the patients.
25
- A representative feature of the health institution’s unique processes,
culture and areas of expertise.
The first reason is unlikely since multiple institutions are covered by cases
and controls in all the data sets. For instance, the training set of the 1Y r
RDNx model included patients from more than 20 institutions. The higher
accuracy of the 1Y rs models compared to the 1Y r models indicates the pos-
sibility that patients that are affiliated with one institution tend to have
more complete records whereas those that are affiliated with multiple insti-
tutions may have gaps in their records. There may also be key demographic
differences between the different health institutions and the availability of
information from certain institutions may bias the results. For instance,
individuals may chose to seek care at different institutions for certain co-
morbidities. If this is the case, the 1Y rs models are excluding patients with
certain comorbidities and are more likely to retain healthier patients. These
aspects will be investigated as part of future work.
In addition to the demographic features, several clinical features are im-
portant. For the 1Y r and 3Y r Rx models, “antidepressants”, “diuretics”,
“antihyperlipedimics” and “antihypertensives” are top features. For the
1Y rs Rx model, “diuretics” and “antihyperlipedimics” are less important
than “psychotherapeutic & neurological agents” and “analgesics - opiod”.
For the Dx data set, “hypertensive disorders”, “hypercholesterolemia”,
“chronic ischemic heart disease”, “depression” and “other cardiovascular dis-
eases” have a high CD. These results validate the experts’ opinion that these
disease groups are important predictors. However, the results also show that
the disease groups “other acute ischemic heart diseases” and “transient is-
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chemic attack related syndromes” are not necessarily strong predictors. This
finding is counterintuitive since “chronic ischemic heart disease” is a strong
predictor. We believe that one potential explanation for the low importance
of the disease groups “other acute ischemic heart diseases” and “transient is-
chemic attack related syndromes” is due to the low incidence rates associated
with these features in the data set used in this study. Indeed, only 32 and
40 patients out of the 3,456 used for the training of the 1Y r Dx model had
“other acute ischemic heart diseases” and “transient ischemic attack related
syndromes”, respectively.
As discussed in Section 3, the Dx models are developed using a top-down
approach. In this case, most of the disease groups identified by the do-
main experts are confirmed by the model as strong predictors for dementia
with the exception of “other acute ischemic heart diseases” and “transient
ischemic attack related syndromes”. Another validation of these features as
strong predictors can be derived by comparison with the Rx models which
were developed using a bottom-up approach (i.e., with no pre-conditioning).
For instance the top feature “depression” in the Dx models aligns with the
drug group “antidepressants” in the Rx models. Similarly, “hypertensive
disorders” aligns with the “antihypertensives” drug group and “hypercholes-
terolemia” aligns with the “antihyperlipidemics” drug group. Moreover, “di-
uretics” are most commonly prescribed for “hypertensive disorders”. This
correlation between the top features of the Rx and Dx models reinforces the
validity of the disease groups identified by domain experts as strong predic-
tors.
In addition to the age and institution, the top features for the Nx model
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are “accurate”, “independently”, “oral”, “oldest”, “participate”, and “radi-
ology”. These labels are representative of a cluster of keywords. For instance,
the clusters “accurate” and “participate” have a DF > 4.3.
The top clinical features of the RDNx models include “oldest”, “oral”,
“participate”, “independently” and “antihyperlidemics”. The first four are
also top features of the Nx models and the fifth is a top feature of the Rx
model. The three institution features (i.e., InstNx, InstDx and InstRx) also
appear as top features in the combined RDNx models. They were omitted
in the RDNx w/o Inst model and the top features of the resulting model are
primarily from the Nx data set.
The results also show that the predictive accuracy of the 1Y rs RDNx w/o
Inst model is impacted the least by the removal of the institution feature
and the 3Y r RDNx w/o Inst model is impacted the most. This fact seem to
reinforce that the institution feature may be an indication of the completeness
of the patient’s records.
As a final step in the analysis of the proposed models, we wanted to
understand the distribution of the cases and controls that are accurately
predicted by the proposed models. For this purpose, we focused on the
combined RDNx models since they had the highest predictive accuracy. The
goal of this analysis is to identify salient characteristics of the cases or controls
that may have contributed towards a higher prediction accuracy. The cases
and controls of the 1Y r and 3Y r RDNx models are affiliated with multiple
institutions regardless of whether the prediction is correct or not. The cases
and controls of the 1Y rs RDNx models were selected based on their affiliation
with a single institution. Patients from multiple institutions are included in
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the test data sets and there are no bias toward higher predictive accuracy
with one institution versus another.
6. Conclusion
Models based on routine care EMR data collected prior to dementia can
help identify high risk individuals from the general patient population and
support the development of a customized health plan based interventions at
various points in the progression trajectory of the disease.
This paper presents a methodology for constructing ML models for de-
mentia prediction by using structured and unstructured routine care EMR
data. Several RF models are developed from three EMR data sets, namely,
drug prescription (Rx), diagnosis (Dx) and medical notes (Nx). The highest
accuracy was obtained with a model that combines these three data sets and
uses a total number of 235 features. This combined model is generalizable
across multiple institutions and can predict dementia within one year of its
onset with an accuracy of 77.43% , a sensitivity of 76.01% and a specificity of
74.16%. Moreover, the model was analyzed and was found not to be affected
by biases related to institution affiliation, race or gender.
Using routine care EMR data to develop the proposed models makes them
accessible to a wide range of patients at a reduced cost. Despite this fact,
the proposed models have a performance comparable to dementia models
that are based on specialized medical tests such as MRI and cognitive tests
(Table 1). One potential use of the proposed models is for the pre-screening
for dementia in the general patient population. A step that can then be
followed by targeted medical tests for patients that are at-risk.
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Top demographics and clinical features were identified by the models. In
the demographic feature set, institution affiliation and age are found to be
important predictors while race and gender are not. The clinical features
are extracted from prescriptions, diagnosis and medical notes. The diagnosis
features suggested by domain experts were confirmed by the exploratory
models developed from the prescriptions data set. The study also shows
that medical notes are the best source of predictive features. These features
require further analysis in order to understand their clinical relationship to
cognitive and executive functioning.
Future work include improving the proposed clustering approach and po-
tentially combining it with word embedding techniques while maintaining
interpretability. We also would like to pursue an aggressive feature reduction
technique as a minimalist model is more cost-effective to deploy in production
across multiple institutions.
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